Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Patent
1979-06-04
1980-09-02
Jiles, Henry R.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
548336, 548342, 548337, 260325PH, C07D23364, A61U 3145
Patent
active
042206545
ABSTRACT:
There are disclosed novel compounds described as imidazole cyanoguanidines in which the imidazole moiety is connected to the cyanoguanidine moiety through a cyclic group which may optionally contain one or two alkylene linkages. The cyclic groups may be phenyl, cyclohexyl, thienyl and the like. Processes for the preparation of such compounds are also disclosed. The compounds are useful for the suppression of gastric acid secretion in mammals, and compositions for such uses are also disclosed.
REFERENCES:
patent: 3897444 (1975-07-01), Durant et al.
patent: 3932443 (1976-01-01), White
patent: 3950333 (1976-04-01), Durant et al.
patent: 3979398 (1976-09-01), White
patent: 4000296 (1976-12-01), Durant et al.
patent: 4038408 (1977-07-01), Durant et al.
patent: 4049671 (1977-09-01), Durant et al.
patent: 4083988 (1978-04-01), Durant et al.
patent: 4093621 (1978-06-01), Brown et al.
patent: 4098898 (1978-07-01), Durant et al.
patent: 4109003 (1978-08-01), Durant et al.
patent: 4112234 (1978-09-01), Crenshaw et al.
patent: 4128658 (1978-12-01), Price et al.
Yamanouchi Pharmaceutical Co., Derwent Abstract 75065A/42 and 750654A/42.
Bolhofer William A.
Cragoe, Jr. Edward J.
Hoffman, Jr. Jacob M.
Fan Jane T.
Jiles Henry R.
Merck & Co. , Inc.
Rose David L.
Westlake Harry E.
LandOfFree
Cyclic imidazole cyanoguanidines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic imidazole cyanoguanidines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic imidazole cyanoguanidines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1708582